Paul Frederick Burton - 30 Sep 2026 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Reporting relationship
Director
Issuer ticker
CDIO
Reported as of
30 Sep 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Oct 2026, 17:29:34 UTC
Prior SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elisa Luqman as attorney in fact for Paul Burton

Key filing fact

Paul Frederick Burton filed Form 4 for Cardio Diagnostics Holdings, Inc. (CDIO) on 02 Oct 2026.

Key facts

  • This page summarizes Paul Frederick Burton's Form 4 filing for Cardio Diagnostics Holdings, Inc. (CDIO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 02 Oct 2026, 17:29.

Change

  • Previous filing in this sequence was filed on 02 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002006956 Primary reporting owner

Burton Paul Frederick

Relationship
Director
Address
311 W. SUPERIOR STREET, SUITE 444, C/O CARDIO DIAGNOSTICS HOLDINGS INC., CHICAGO
Signature
/s/ Elisa Luqman as attorney in fact for Paul Burton
Signature date
02 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDIO transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
Shares
+3,286
Change %
+25%
Price
$1.90*
Shares after
16,607
Date
30 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,286
Exercise price
$1.90
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .